ATLASATLAS fair value
HK$1.15
Below fair value · 25% discount
Range: HK$0.774–HK$1.70Fair valuePrice
C-Mer Eye Care (3309.HK)
C-Mer Eye Care share price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Hong Kong Exchanges (HKEX) · Hong Kong SAR China
HK$0.865▲ +2.37%
Prices as of Oct 27, 2026 · HKD
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on C-Mer Eye Care in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On C-Mer Eye Care
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates C-Mer Eye Care's fair value at about HK$1.15 per share (reasonable range: HK$0.774 to HK$1.70). At HK$0.865, the stock trades 25% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives C-Mer Eye Care a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between HK$0.809 and HK$0.924; in 9 out of 10, between HK$0.720 and HK$1.04. Estimated annual volatility is 39%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- HK$918M
- Market cap (USD)
- $117M
- P/E ratio
- 9.7
- Dividend yield
- 2.52%
- 52-week high
- HK$1.88
- 52-week low
- HK$0.730
- Revenue (12 months)
- HK$2.0B
- Gross margin
- 31.2%
- Operating margin
- 8.9%
- Net margin
- 5.0%
- Beta
- 0.56
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. C-Mer Eye Care sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 3309.HK has traded between HK$0.730 and HK$1.88. Today it is 54.0% below that high and 18% above its low.
On the business: net margin is 5.0%; it trades at 9.7 times earnings.
Its beta is 0.56: it tends to move less than the market.
About the company
C-MER Medical Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China.
Want to see everything about C-Mer Eye Care?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is C-Mer Eye Care (3309.HK) fair value?
About HK$1.15 per share according to ATLAS (reasonable range: HK$0.774 to HK$1.70). With the stock at HK$0.865, it is 25% below it.
What is the chance 3309.HK goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, 3309.HK ends the month between HK$0.809 and HK$0.924.
How big is C-Mer Eye Care and what is its P/E ratio?
C-Mer Eye Care's market capitalization is HK$918M. Its price-to-earnings (P/E) ratio is 9.7: you pay HK$9.69 for each HK$1.00 of yearly earnings.
Does C-Mer Eye Care pay a dividend?
Yes. 3309.HK's current dividend yield is 2.52% at today's price (HK$0.865).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer